Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:07:48.567Z.
Calculation as of: 2026-10-06T17:07:48.567Z.
Quote observation: 2026-10-06T17:05:21.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 757805bafeebc6dd018a704dcae2ac70006cc574d7bdbc7e38b059e75a8ad8a2
EARNINGS YIELD
N/A
Lumexa Imaging Holdings, Inc. Common Stock
Market Cap
$1.02B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.03B
Earnings Yield
N/A
TTM Avg
1.59%
3Y Avg
1.59%
5Y Avg
0.91%
Market Cap
$1.04B
Earnings Yield
N/A
TTM Avg
2.18%
3Y Avg
3.28%
5Y Avg
2.72%
Market Cap
$1.04B
Earnings Yield
N/A
TTM Avg
17.88%
3Y Avg
17.88%
5Y Avg
17.88%
Market Cap
$990.27M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.02B | N/A | N/A | N/A | N/A |
| Castle Biosciences, Inc. (CSTL)vs › | $1.03B | N/A | 1.59% | 1.59% | 0.91% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.03B | N/A | N/A | N/A | N/A |
| Immatics N.V. (IMTX)vs › | $1.03B | N/A | 3.22% | 5.54% | 5.54% |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.04B | N/A | 2.18% | 3.28% | 2.72% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.04B | N/A | 17.88% | 17.88% | 17.88% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | N/A | N/A | N/A | N/A |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $990.27M | N/A | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $977.47M | 1.41% | 1.18% | 2.75% | 2.30% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
